McElroy Susan L, Frye Mark A, Suppes Trisha, Dhavale Dawn, Keck Paul E, Leverich Gabriele S, Altshuler Lori, Denicoff Kirk D, Nolen Willem A, Kupka Ralph, Grunze Heinz, Walden Jorg, Post Robert M
Stanley Foundation Bipolar Treatment Outcome Network, Department of Psychiatry, University of Cincinnati College of Medicine, Ohio 45267-0559, USA.
J Clin Psychiatry. 2002 Mar;63(3):207-13. doi: 10.4088/jcp.v63n0306.
Overweight and obesity are common clinical problems encountered in the treatment of bipolar disorder. We therefore assessed the prevalence and clinical correlates of overweight, obesity, and extreme obesity in 644 bipolar patients.
644 outpatients with DSM-IV bipolar disorder in the Stanley Foundation Bipolar Treatment Outcomes Network were evaluated with structured diagnostic interviews and clinician- and self-administered questionnaires to determine bipolar disorder diagnoses, demographic and historical illness characteristics, comorbid Axis I diagnoses, medical histories, health habits, and body mass indices (BMMs).
Fifty-eight percent of the patients with bipolar disorder were overweight, 21% were obese, and 5% were extremely obese. American patients had significantly higher mean (p < .0001) BMIs and significantly higher rates of obesity (p < .001) and extreme obesity (p < .001) than European patients. Significant associations (p < or = .001) were found between overweight, obesity. and extreme obesity and gender, age, income level, comorbid binge-eating disorder, hypertension, arthritis, diabetes mellitus, exercise habits, and coffee consumption. Current BMI and weight were each correlated with the number of weight gain-associated psychotropics to which patients had been exposed. Multinomial logistic regression (adjusted for site and eating disorder diagnosis and corrected for multiple comparisons) showed that (1) overweight was significantly associated with male gender and hypertension (p < .001), (2) obesity was significantly associated with hypertension (p < .001), and (3) extreme obesity was significantly associated with hypertension and arthritis (p < .001).
Overweight, obesity, and extreme obesity were common in this group of bipolar patients, although it was unclear that their prevalence rates were truly elevated, because overweight and obesity are increasingly common public health problems among the general population. Correlates of overweight and obesity in bipolar disorder include patient and treatment variables such as gender, geographical location, comorbid binge-eating disorder, age, income level, degree of exposure to weight gain-associated psychotropics, medical disorders associated with obesity, and health habits.
超重和肥胖是双相情感障碍治疗中常见的临床问题。因此,我们评估了644例双相情感障碍患者中超重、肥胖及极度肥胖的患病率及其临床相关因素。
对斯坦利基金会双相情感障碍治疗结果网络中的644例符合DSM-IV双相情感障碍诊断标准的门诊患者进行结构化诊断访谈,并通过临床医生和患者自行填写的问卷,以确定双相情感障碍的诊断、人口统计学和病史特征、共病的轴I诊断、病史、健康习惯及体重指数(BMI)。
双相情感障碍患者中,58%超重,21%肥胖,5%极度肥胖。美国患者的平均BMI显著高于欧洲患者(p <.0001),肥胖率(p <.001)和极度肥胖率(p <.001)也显著更高。超重、肥胖及极度肥胖与性别、年龄、收入水平、共病的暴饮暴食症、高血压、关节炎、糖尿病、运动习惯及咖啡摄入量之间存在显著关联(p≤.001)。当前的BMI和体重均与患者接触过的与体重增加相关的精神药物数量相关。多项逻辑回归分析(校正了研究地点和饮食失调诊断,并对多重比较进行了校正)显示:(1)超重与男性及高血压显著相关(p <.001);(2)肥胖与高血压显著相关(p <.001);(3)极度肥胖与高血压及关节炎显著相关(p <.001)。
超重、肥胖及极度肥胖在这组双相情感障碍患者中很常见,不过尚不清楚其患病率是否真的有所升高,因为超重和肥胖在普通人群中是日益常见的公共卫生问题。双相情感障碍中超重和肥胖的相关因素包括患者及治疗变量,如性别、地理位置、共病的暴饮暴食症、年龄、收入水平、接触与体重增加相关精神药物的程度、与肥胖相关的躯体疾病及健康习惯。